Text Size

Health Outcomes in Rheumatoid Arthritis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2006 by Johns Hopkins University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00346411
First received: June 28, 2006
Last updated: NA
Last verified: May 2006
History: No changes posted
  Purpose

This research is being done to help us learn about how different factors related to treatment affect rheumatoid arthritis (RA). This is not a treatment study. We will follow the patient for one year as he or she receives usual treatment from his or her rheumatologist. Up to 360 adults with RA may join this study.


Condition
Rheumatoid Arthritis

Study Type: Observational
Study Design: Additional Descriptors: Psychosocial
Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Health Outcomes in Rheumatoid Arthritis

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Johns Hopkins University:

Estimated Enrollment: 260
  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Males and females age 19 or older
  • Current active, adult-onset rheumatoid arthritis who meet ACR criteria for RA and have: (American College of Rheumatology [ACR] functional class I–III), defined as:
  • 3 or more swollen or tender joints and
  • Morning stiffness of 45min or longer
  • OR judged by their rheumatologist to have active disease
  • No evidence of other inflammatory diseases (e.g., Crohn’s, IBS)
  • Functional class I, II or III

Exclusion Criteria:

  • Individuals with significant cardiovascular disease (CHF, stroke, MI)
  • Unwilling to have medications monitored and/or comply with protocol
  • Not fluent in English
  • Planning to move from area within next year or change health insurance (which would preclude ongoing care by JH rheumatologist)
  • Enrolled in study evaluating efficacy of new or existing RA medications
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00346411

Contacts
Contact: Steffany Haaz, MFA (410) 550-5216 shaaz1@jhmi.edu
Contact: Susan Bartlett, PhD (410) 550-7775 bartlett@jhmi.edu

Locations
United States, Maryland
Johns Hopkins Bayview Campus Recruiting
Baltimore, Maryland, United States, 21224
Contact: Steffany Haaz, MFA     410-550-5216     shaaz1@jhmi.edu    
Contact: Susan Bartlett, PhD     (410) 550-7775     bartlett@jhmi.edu    
Principal Investigator: Susan Bartlett, PhD            
Good Samaritan Hospital Recruiting
Baltimore, Maryland, United States, 21239
Contact: Clifford Bingham, MD     410-532-4646     clifton.bingham@JHMI.edu    
Sub-Investigator: Clifford Bingham, MD            
Sponsors and Collaborators
Johns Hopkins University
Investigators
Principal Investigator: Susan Bartlett, PhD Johns Hopkins School of Medicine
Study Director: Steffany Haaz, MFA Johns Hopkins University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00346411     History of Changes
Other Study ID Numbers: NA_00001359
Study First Received: June 28, 2006
Last Updated: June 28, 2006
Health Authority: United States: Institutional Review Board

Keywords provided by Johns Hopkins University:
rheumatoid arthritis
mood
adherence
medication

Additional relevant MeSH terms:
Arthritis
Arthritis, Rheumatoid
Joint Diseases
Musculoskeletal Diseases
 Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases

ClinicalTrials.gov processed this record on June 17, 2013